Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. (Q54080708)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. (English)

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

type 2 diabetes

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jacob S

1

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Ruus P

2

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Hermann R

3

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Tritschler HJ

4

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Maerker E

5

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Renn W

6

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Augustin HJ

7

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Dietze GJ

8

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Rett K

9

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

publication date

1 August 1999

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Free Radical Biology and Medicine

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

27

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

3-4

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

309-314

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

Characterization of cellular defects of insulin action in type 2 (non-insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis of NIDDM. A balanced overview

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Physical activity and incidence of non-insulin-dependent diabetes mellitus in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Gliclazide and insulin action in human muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of sulfonylurea withdrawal on proinsulin levels, B cell function, and glucose disposal in subjects with noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of acarbose on insulin sensitivity in subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of short-term alpha-glucosidase inhibition on carbohydrate and lipid metabolism in type II (noninsulin-dependent) diabetics.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Short administration of metformin improves insulin sensitivity in android obese subjects with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of insulin sensitivity by metformin treatment does not lower blood pressure of nonobese insulin-resistant hypertensive patients with normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation of glucose utilization by thioctic acid in rat diaphragm incubated in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Stimulation by alpha-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of thioctic acid on metabolism and function of the diabetic heart

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Improvement of insulin-stimulated glucose-disposal in type 2 diabetes after repeated parenteral administration of thioctic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of DL-alpha-lipoic acid on the citrate concentration and phosphofructokinase activity of perfused hearts from normal and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2899%2900089-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0891-5849(99)00089-1

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

1 reference

Europe PubMed Central

24 May 2018

http://europepmc.org/abstract/MED/10468203

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54080708&oldid=1409921541"